Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)

Beatriz Larraz-Prieto; Louise Hjorth Lind; Jacob Bastholm Olesen; Asim Azfer; Morten Svarer Hansen; Morten Frost; Abbas Jafari; Colin Farquharson; Stuart H. Ralston; Kent Søe; Nerea Alonso

doi:10.1302/2046-3758.148.BJR-2025-00005

Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)

Beatriz Larraz-Prieto
, Louise Hjorth Lind
, Jacob Bastholm Olesen
, Asim Azfer
, Morten Svarer Hansen
, Morten Frost
, Abbas Jafari
, Colin Farquharson
, Stuart H. Ralston
, Kent Søe
, Nerea Alonso

Research output: Contribution to journal › Comment/debate › Research › peer-review

Abstract

An incomplete version of the funding statement was originally published. The correct funding statement is as follows: The author(s) disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the Odense University Hospital and the Region of Southern Denmark (Grant ID 20/43354) supported the work by L. H. Lind and K. Søe; the Austrian Fonds zur Förderung der wissenschaftlichen Forschung, FWF (Grant-DOI: 10.55776/ PAT4629323) was awarded to N. Alonso, as well as the Moray Endowment Award from the University of Edinburgh (grant number 416MOR), which funded the protein analysis for this study; the Institute of Genetics and Cancer (PhD research studentship to B. Larraz-Prieto); the Olav Thon Foundation, the Gerda and Aage Haensch Foundation, Director Michael Herman Nielsen’s Foundation, and the Doctor Sofus Carl Emil Friis and Olga Doris Friis Foundation, which funded lab work and salary costs for A. Jafari. C. Farquharson reports Institute Strategic Programme Grant Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/D/10002071 and BBS/E/RL/230001C) for this study. The other authors received no financial or material support for the research, authorship, and/or publication of this article.

Original language	English
Journal	Bone and Joint Research
Volume	14
Issue number	8
Pages (from-to)	746
Number of pages	1
ISSN	2046-3758
DOIs	https://doi.org/10.1302/2046-3758.148.BJR-2025-00005
Publication status	Published - Aug 2025

Funding

Published online date: 16 May 2025 https:// boneandjoint.org.uk/Article/10.1302/2046-3758.145.BJR-2024-0167.R1 An incomplete version of the funding statement was originally published. The correct funding statement is as follows: The author(s) disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the Odense University Hospital and the Region of Southern Denmark (Grant ID 20/43354) supported the work by L. H. Lind and K. Søe; the Austrian Fonds zur Förderung der wissenschaftli-chen Forschung, FWF (Grant-DOI: 10.55776/ PAT4629323) was awarded to N. Alonso, as well as the Moray Endowment Award from the University of Edinburgh (grant number 416MOR), which funded the protein analysis for this study; the Institute of Genetics and Cancer (PhD research studentship to B. Larraz-Prieto); the Olav Thon Foundation, the Gerda and Aage Haensch Foundation, Director Michael Herman Nielsen’s Foundation, and the Doctor Sofus Carl Emil Friis and Olga Doris Friis Foundation, which funded lab work and salary costs for A. Jafari. C. Farquharson reports Institute Strategic Programme Grant Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/D/10002071 and BBS/E/RL/230001C) for this study. The other authors received no financial or material support for the research, authorship, and/or publication of this article. The correct version is now available online.

Documents & Links

10.1302/2046-3758.148.BJR-2025-00005

SDU Link

Check access to the material in SDU Library's search engine

Fingerprint

Dive into the research topics of 'Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)'. Together they form a unique fingerprint.

CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro
Larraz-Prieto, B., Lind, L. H., Olesen, J. B., Azfer, A., Hansen, M. S., Frost, M., Jafari, A., Ralston, S. H., Søe, K. & Alonso, N., 16. May 2025, In: Bone & Joint Research. 14, 5, p. 463-476
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File
18 Downloads (Pure)

Cite this

Larraz-Prieto, B., Lind, L. H., Olesen, J. B., Azfer, A., Hansen, M. S., Frost, M., Jafari, A., Farquharson, C., Ralston, S. H., Søe, K., & Alonso, N. (2025). Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1). Bone and Joint Research, 14(8), 746. https://doi.org/10.1302/2046-3758.148.BJR-2025-00005

@article{9ef01b08e3a644c2a3445463ecdb94d8,

title = "Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone \& Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)",

abstract = "An incomplete version of the funding statement was originally published. The correct funding statement is as follows: The author(s) disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the Odense University Hospital and the Region of Southern Denmark (Grant ID 20/43354) supported the work by L. H. Lind and K. S{\o}e; the Austrian Fonds zur F{\"o}rderung der wissenschaftlichen Forschung, FWF (Grant-DOI: 10.55776/ PAT4629323) was awarded to N. Alonso, as well as the Moray Endowment Award from the University of Edinburgh (grant number 416MOR), which funded the protein analysis for this study; the Institute of Genetics and Cancer (PhD research studentship to B. Larraz-Prieto); the Olav Thon Foundation, the Gerda and Aage Haensch Foundation, Director Michael Herman Nielsen{\textquoteright}s Foundation, and the Doctor Sofus Carl Emil Friis and Olga Doris Friis Foundation, which funded lab work and salary costs for A. Jafari. C. Farquharson reports Institute Strategic Programme Grant Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/D/10002071 and BBS/E/RL/230001C) for this study. The other authors received no financial or material support for the research, authorship, and/or publication of this article.",

author = "Beatriz Larraz-Prieto and Lind, \{Louise Hjorth\} and Olesen, \{Jacob Bastholm\} and Asim Azfer and Hansen, \{Morten Svarer\} and Morten Frost and Abbas Jafari and Colin Farquharson and Ralston, \{Stuart H.\} and Kent S{\o}e and Nerea Alonso",

year = "2025",

month = aug,

doi = "10.1302/2046-3758.148.BJR-2025-00005",

language = "English",

volume = "14",

pages = "746",

journal = "Bone and Joint Research",

issn = "2046-3758",

publisher = "British Editorial Society of Bone and Joint Surgery",

number = "8",

}

Larraz-Prieto, B, Lind, LH , Olesen, JB, Azfer, A, Hansen, MS , Frost, M, Jafari, A, Farquharson, C, Ralston, SH, Søe, K & Alonso, N 2025, 'Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)', Bone and Joint Research, vol. 14, no. 8, pp. 746. https://doi.org/10.1302/2046-3758.148.BJR-2025-00005

Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1). / Larraz-Prieto, Beatriz; Lind, Louise Hjorth ; Olesen, Jacob Bastholm et al.
In: Bone and Joint Research, Vol. 14, No. 8, 08.2025, p. 746.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - Erratum

T2 - CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)

AU - Larraz-Prieto, Beatriz

AU - Lind, Louise Hjorth

AU - Olesen, Jacob Bastholm

AU - Azfer, Asim

AU - Hansen, Morten Svarer

AU - Frost, Morten

AU - Jafari, Abbas

AU - Farquharson, Colin

AU - Ralston, Stuart H.

AU - Søe, Kent

AU - Alonso, Nerea

PY - 2025/8

Y1 - 2025/8

N2 - An incomplete version of the funding statement was originally published. The correct funding statement is as follows: The author(s) disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the Odense University Hospital and the Region of Southern Denmark (Grant ID 20/43354) supported the work by L. H. Lind and K. Søe; the Austrian Fonds zur Förderung der wissenschaftlichen Forschung, FWF (Grant-DOI: 10.55776/ PAT4629323) was awarded to N. Alonso, as well as the Moray Endowment Award from the University of Edinburgh (grant number 416MOR), which funded the protein analysis for this study; the Institute of Genetics and Cancer (PhD research studentship to B. Larraz-Prieto); the Olav Thon Foundation, the Gerda and Aage Haensch Foundation, Director Michael Herman Nielsen’s Foundation, and the Doctor Sofus Carl Emil Friis and Olga Doris Friis Foundation, which funded lab work and salary costs for A. Jafari. C. Farquharson reports Institute Strategic Programme Grant Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/D/10002071 and BBS/E/RL/230001C) for this study. The other authors received no financial or material support for the research, authorship, and/or publication of this article.

AB - An incomplete version of the funding statement was originally published. The correct funding statement is as follows: The author(s) disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the Odense University Hospital and the Region of Southern Denmark (Grant ID 20/43354) supported the work by L. H. Lind and K. Søe; the Austrian Fonds zur Förderung der wissenschaftlichen Forschung, FWF (Grant-DOI: 10.55776/ PAT4629323) was awarded to N. Alonso, as well as the Moray Endowment Award from the University of Edinburgh (grant number 416MOR), which funded the protein analysis for this study; the Institute of Genetics and Cancer (PhD research studentship to B. Larraz-Prieto); the Olav Thon Foundation, the Gerda and Aage Haensch Foundation, Director Michael Herman Nielsen’s Foundation, and the Doctor Sofus Carl Emil Friis and Olga Doris Friis Foundation, which funded lab work and salary costs for A. Jafari. C. Farquharson reports Institute Strategic Programme Grant Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/D/10002071 and BBS/E/RL/230001C) for this study. The other authors received no financial or material support for the research, authorship, and/or publication of this article.

U2 - 10.1302/2046-3758.148.BJR-2025-00005

DO - 10.1302/2046-3758.148.BJR-2025-00005

M3 - Comment/debate

C2 - 40859788

AN - SCOPUS:105018074108

SN - 2046-3758

VL - 14

SP - 746

JO - Bone and Joint Research

JF - Bone and Joint Research

IS - 8

ER -

Erratum: CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro (Bone & Joint Research (2025) 14:5 (463-476) DOI: 10.1302/2046-3758.145.BJR-2024-0167.R1)

Abstract

Funding

Documents & Links

SDU Link

Fingerprint

Related research output

CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro

Cite this